Skip to main content

Home/ Groups/ OARS funding Cancer
MiamiOH OARS

Limited Competition: AIDS and Cancer Specimen Resource (ACSR)(UM1 Clinical Trials Not A... - 0 views

  •  
    Through this limited competition Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) solicits a single application for the continuation of the AIDS and Cancer Specimen Resource (ACSR). The eligible applicant institutions (which are the two current NCI-supported ACSR lead institutions) are expected to maintain the cooperative group structure and the activities of the ACSR. The primary objective of the ACSR will be to acquire, store, and equitably distribute tumor tissues, biological fluids, and associated demographic data from patients with human immunodeficiency virus (HIV)-associated malignancies. In addition to serving acquired immunodeficiency syndrome (AIDS) and cancer researchers at large, the ACSR will specifically provide biorepository functions for another NCI supported initiative, the AIDS Malignancy Consortium (AMC). The AMC performs clinical trials research in the treatment and prevention of HIV-associated malignancies in the United States and Sub-Saharan Africa. As the AMC is currently expanding its agenda to include Latin America, it is expected that the ACSR will collaborate with the AMC to develop regional biorepository support for AMC activities in Latin American countries. The continuing ACSR must have appropriate strategies and capabilities to address several high priority areas of specimen acquisition including specific types of cancer (AIDS-defining as well as non-AIDS defining), types of biospecimens and accompanying clinical data, and biospecimens from geographic areas of interest.
MiamiOH OARS

NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) - 0 views

  •  
    This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for core/shared resource/central scientific support scientists. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical or population science cancer research program, but not serve as independent investigators. These scientists, such as researchers within a core/shared resource/central scientific support, are vital to sustaining the biomedical research enterprise. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others for career continuity.
MiamiOH OARS

NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allo... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for core/shared resource/central scientific support scientists. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical or population science cancer research program, but not serve as independent investigators. These scientists, such as researchers within a core/shared resource/central scientific support, are vital to sustaining the biomedical research enterprise. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others for career continuity.
MiamiOH OARS

Gulf War Illness, New Investigator Award - 0 views

  •  
    The intent of the GWIRP NIA is to support investigators new to the field of GWI research at different stages of career development. This award enables such investigators to compete for funding separately from investigators with established programs of GWI research. Previous experience in GWI research is allowed, but not required. However, applications naming a Principal Investigator (PI) with limited background in GWI research are strongly encouraged to include collaboration with investigators who are experienced in GWI research and/or possess other relevant expertise to strengthen the application. The application should describe how the collaboration(s) will augment the PI's ability to address the research question.
MiamiOH OARS

NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) - 0 views

  •  
    This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research. The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA. It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research.
MiamiOH OARS

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) - 0 views

  •  
    This funding opportunity announcement (FOA) invites applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, and implementation science.
MiamiOH OARS

Rivkin Center for Ovarian Cancer Research Invites Applications for Scientific Scholar A... - 0 views

  •  
    Through the program, the center will award grants of up to $120,000 over two years to promising laboratory and clinical scientists pursuing careers as independent investigators in ovarian cancer research. Funds are for direct costs only; institutional overhead and indirect costs will not be included in the award.

MiamiOH OARS

DoD Breast Cancer, Breakthrough Award Levels 1 and 2 - 0 views

  •  
    Impact: Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must move beyond a minor advancement and have the potential to lead to a new approach that is fundamentally better than interventions already approved or in clinical development. Applications are expected to identify the breast cancer patients or at-risk individuals who would ultimately benefit from the proposed research.
MiamiOH OARS

DoD Breast Cancer, Breakthrough Award Levels 3 and 4 - 0 views

  •  
    Impact: Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must move beyond a minor advancement and have the potential to lead to a new approach that is fundamentally better than interventions already approved or in clinical development. Applications are expected to identify the breast cancer patients or at-risk individuals who would ultimately benefit from the proposed research.
MiamiOH OARS

Conquer Cancer Foundation Accepting Applications for Annual Career Development Award | ... - 0 views

  •  
    The Conquer Cancer Foundation was created by the American Society of Clinical Oncology to drive dramatic advances in the prevention, treatment, and cures of all types of cancer. CCF works to conquer cancer by funding breakthrough cancer research and sharing cutting-edge knowledge with patients and physicians worldwide, improving quality of and access to care, and enhancing quality of life for all who are touched by cancer.

MiamiOH OARS

Hirschberg Foundation Invites Applications for Pancreatic Cancer Research Grants | RFPs... - 0 views

  •  
    The annual program provides start-up funding to basic scientists and clinicians in a position to test innovative ideas for improving the diagnosis of and new treatment modalities for pancreatic cancer; obtain preliminary data required for additional funding from other agencies for pancreatic cancer research;  advance the understanding of pancreatic cancer cell biology, biochemistry, physiology, morphology and response to therapy; and establish collaborations within the field that can be considered for further funding. The foundation expects that seed grant awards will generate quality abstracts, papers, and presentations, as well as new proposals. Priority will be given to investigators whose primary intent is to build a strong curriculum in pancreatic cancer research.

MiamiOH OARS

DoD Peer Reviewed Cancer, Horizon Award - 0 views

  •  
    The FY18 PRCRP Horizon Award supports junior-level scientists in conducting impactful research with the mentorship of an experienced cancer researcher (i.e., Mentor). The Horizon Award challenges junior scientists to develop and implement research in the cancer field. This opportunity allows for junior investigators to develop a research project, investigate a problem or question in the field of cancer, and further their intellectual development as a cancer researcher of the future.
MiamiOH OARS

National Foundation for Cancer Research Issues Call for Nominations for 2019 ... - 0 views

  •  
    The annual prize, named in honor of Albert Szent-Györgyi, Nobel Laureate and co-founder of NFCR, is awarded to an outstanding researcher whose scientific achievements have expanded our understanding of cancer and whose discoveries have made possible new approaches to the prevention, diagnosis, and/or treatment of cancer.

MiamiOH OARS

Administrative Supplements to Promote Collaborative Activities in Basic Cancer Research... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to incentivize collaborative, multidisciplinary research across a broad area of challenging topics in basic cancer biology. These supplement applications must propose a collaboration between at least two researchers, one being the PI of the parent NCI grant. Awarded supplements will leverage and extend currently funded cancer research in the parent grant.
MiamiOH OARS

Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative ... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement applications to develop research resources that will encourage a consensus on how Quantitative Imaging (QI) methods are optimized to improve the quality of imaging results for co-clinical trials. The scientific goals of this FOA are to: (a) perform the appropriate optimization of the pre-clinical quantitative imaging methods, (b) implement the optimized methods in the co-clinical trial, and finally (c) populate a web-accessible research resource with all the data, methods, workflow documentation, and results collected from the co-clinical investigations. Co-clinical trials are defined in this FOA as investigations in patients and in parallel (or sequentially) in mouse or human-in-mouse models of cancer that mirror the genetics and biology of the patients malignancies or pre-cancerous lesions. The co-clinical trial should include either (a) a therapeutic goal, such as the prediction, staging, and/or measurement of tumor response to therapies, or (b) a screening and early detection or a cancer risk stratification goal for lethal cancer versus non-lethal disease. Applicants are encouraged to organize multi-disciplinary teams with experience in mouse models research, human investigations, imaging platforms, QI methods, decision support software and informatics to populate the research resource.
MiamiOH OARS

Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical... - 0 views

  •  
    The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. This FOA is intended to accelerate and strengthen multi-disciplinary cancer disparities research in wide-ranging areas. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden and/or response to treatment in racial/ethnic minorities and/or underserved population groups. Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets. Importantly, the supplemental proposal is required to be within the scope of the parent award and should expand the original aims to include a cancer disparity component.
MiamiOH OARS

PA-18-842: Administrative Supplements to Support Cancer Disparity Collaborative Researc... - 0 views

  •  
    The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. This FOA is intended to accelerate and strengthen multi-disciplinary cancer disparities research in wide ranging areas. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden and/or response to treatment in racial/ethnic minorities and/or underserved population groups. Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets. Importantly, the supplemental request is required to be within the scope of the parent award and should expand the original aims to include a cancer disparity component.
MiamiOH OARS

PAR-18-841: Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Q... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement applications to develop research resources that will encourage a consensus on how Quantitative Imaging (QI) methods are optimized to improve the quality of imaging results for co-clinical trials.



    The scientific goals of this FOA are to:

    (a) perform the appropriate optimization of the pre-clinical quantitative imaging methods,

    (b) implement the optimized methods in the co-clinical trial, and finally

    (c) populate a web-accessible research resource with all the data, methods, workflow documentation, and results collected from the co-clinical investigation
MiamiOH OARS

Lymphoma Research Foundation Accepting Applications for Career Development Award | RFPs... - 0 views

  •  
    To advance this mission, the foundation is accepting applications for its LRF Clinical Investigator Career Development Award program, which is designed to support physician-investigators at the level of advanced fellow or junior faculty member who will contribute to the development of new lymphoma therapies and diagnostic tools. The goal of the program is to prepare physician-investigators to design and administer clinical research studies in lymphoma and assume primary responsibilities for clinical research, protocol writing, Institutional Review Board (IRB) submission, and publication.

MiamiOH OARS

Prostate Cancer, Health Disparity Fellowship Award - 0 views

  •  
    Research Approach: Proposed research ideas are required to address one or more of the FY18 PCRP Overarching Challenges. The scientific rationale and experimental methodology should demonstrate in-depth analysis of the research problem presented and should focus on reducing and ultimately eliminating disparities in prostate cancer incidence, morbidity, and mortality. The proposal must explicitly state how the proposed research is related to a health disparity area within an affected population or community. The PCRP is interested in research that addresses all different aspects that contribute to health disparity in prostate cancer, including, but not limited to, social, cultural, and/or biological contributors. The feasibility of the research design and methods should be well defined, and a clear plan should be articulated as to how the proposed goals of the project can be achieved. The inclusion of preliminary data relevant to prostate cancer and the proposed project is encouraged but not required. Any preliminary data provided should be from the PI, Mentor(s), or member(s) of the collaborating team. Additionally, required resources should be identified and supported through documentation.
‹ Previous 21 - 40 of 595 Next › Last »
Showing 20 items per page